This inventor holds 2 USPTO granted patents. Top assignee: The Upjohn Co.. Active years: 1976-1977.
Company Filing History:
Years Active: 1976-1977
Title: The Innovations of Stephen A Mizsak
Introduction
Stephen A Mizsak is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral agents and nutritional supplements. With a total of 2 patents, Mizsak's work has the potential to impact both health and wellness.
Latest Patents
Mizsak's latest patents include the development of Feldamycic acid, which is derived from the hydrolysis of the antibiotic feldamycin (U-48,266). This compound can be coupled with nutritional amino acids to create peptides that serve as nutritional supplements. Another significant patent is for the antiviral agent U-50,228, which is produced through the controlled fermentation of the microorganism Streptomyces platensis var. clarensis var nova, NRRL 8035. This antiviral agent is effective against DNA viruses, such as the Herpes virus, and can be utilized in laboratory settings to eliminate the presence of such viruses.
Career Highlights
Mizsak is currently associated with The Upjohn Company, where he continues to innovate and develop new pharmaceutical solutions. His work has been instrumental in advancing the understanding and treatment of viral infections.
Collaborations
Some of his notable coworkers include Alexander D Argoudelis and Lubomir Baczynskyj, who have collaborated with Mizsak on various projects within the pharmaceutical industry.
Conclusion
Stephen A Mizsak's contributions to the field of pharmaceuticals through his patents and work at The Upjohn Company highlight his role as an influential inventor. His innovations in antiviral agents and nutritional supplements demonstrate the importance of research and development in improving health outcomes.